Search Results - breast cancer




7 Results Sort By:
Inhibitors of the ubiquitin E3 ligase BCA2 as anti-cancer therapeutic agents
Background:Breast cancer associated protein 2 (BCA2) is a ubiquitin E3 ligase found in invasive breast cancer. Studies have shown that by decreasing its activity, breast cancer cell growth and invasiveness are diminished. Targeting this ligase and inhibiting its activity could play a role in treatment of breast cancer. A molecular approach to in...
Published: 8/3/2017   |   Inventor(s): Angelika Burger, Andrew Westwell
Keywords(s): Analog or Analogue, Breast Cancer, Cancer, Disease, Drug Target, Enzyme
Category(s): Diseases, Oncology, Therapeutics, Life Science, Research tools
Modified Ectodomain of Human EGFR as a Potential Anticancer Agent
Development of a protein that attenuates EGFR and/or EGFR family members and is comprised of a modified EGFR ectodomain. The protein inhibits signaling via the EGFR and/or EGFR family members. The protein includes a portion of the EGFR (or EGFR family member) and the "U" region epitope of EGFR related protein (ERRP), wherein the portion o...
Published: 8/3/2017   |   Inventor(s): Adhip Majumdar, Arun Rishi, Yingjie Yu
Keywords(s): Breast Cancer, Cancer, Cancer Therapies, Disease, Drug Target, Protein, Therapeutics
Category(s): Life Science, Biologicals, Diseases, Oncology
Para-Amino Substituent on the D Ring of Green Tea Polyphenol Epigallocatechin-3-Gallate as Novel Proteasome Inhibitor and Cancer Apoptosis Inducer
This technology is a group of (-)EGCG analogs with stable and improved anti-tumor activities. Background & Unmet Need:Catechins are a type of plant-derived antioxidant whose biological activities may play an effect on cancer prevention. Green tea has long been lauded to have ingredients that protect cells from the DNA damage that causes cancer...
Published: 8/3/2017   |   Inventor(s): Qingping Dou, Kristin Landis-Piwowar, Tak-Hang Chan, Kumi Osanai
Keywords(s): Anti-cancer, Breast Cancer, Compound, Prostate Cancer
Category(s): Life Science, Oncology, Therapeutics, Diseases
Method For Treating and/or Imaging Breast Cancer Using Radioactive Iodine
This invention involves treating a breast cancer patient by the administration of a radioisotope of iodine in a dosage of between 5 and 50 milliCuries over the course of a day. The therapeutic composition is designed for mammary tissue uptake and includes an inorganic radioactive iodide salt (e.g., alkali metal, alkali earth or transition met...
Published: 5/18/2010   |   Inventor(s): James Rillema
Keywords(s): Anti-cancer, Breast Cancer, Cancer Therapies, Imaging, Therapeutics
Category(s): Therapeutics, Life Science, Oncology, Receptors/targets, Diagnostic, Imaging
Antibodies to a Novel Cell Cycle and Apoptosis Regulatory Protein (CARP) -1
Wayne State University researchers have identified a novel cDNA which encodes a pro-apoptotic protein called CARP-1 (Cell Cycle and Apoptosis Regulatory Protein-1), which is expressed in many cancer cell types including breast and colon carcinoma cells. This novel cDNA can be used as a diagnostic and prognostic tool for many types of cancer. Bac...
Published: 5/7/2010   |   Inventor(s): Arun Rishi, Joseph Fontana
Keywords(s): Antibody, Breast Cancer, Cancer, Drug Target
Category(s): Diagnostic, Life Science, Research tools, Antibodies
An In Vitro Model System for Studying Development of Human Preneoplastic Breast Disease
This technology is a novel model/assay system that recapitulates in vitro the in vivo processes that lead to breast cancer development and progression from preneoplastic tissue. This model is the first that demonstrates in vitro the de novo development and neoplastic conversion of functional alveolar units. Background & Unmet Need: Although ...
Published: 5/7/2010   |   Inventor(s): Malathy Shekhar, Larry Tait
Keywords(s): Assay, Breast Cancer
Category(s): Drug Discovery, Assays, Life Science, Oncology, Research tools, Diseases
Tumor Targeting by Small Molecule Therapeutics for a Proton-Coupled Folate Transporter (PCFT)
BackgroundPCFT plays an important role in intestinal folate absorption. The recently cloned proton-coupled folate transporter (PCFT/SLC46A1) is the primary transporter mediating intestinal folate absorption. PCFT displays optimal folate influx activity at acidic pH and recognizes folic acid, reduced folates (e.g. 6S-5-CH3-THF) and the antifolate ...
Published: 5/6/2010   |   Inventor(s): Larry Matherly, Aleem Gangjee
Keywords(s): Analog or Analogue, Breast Cancer, Cancer Therapies, Drug Delivery, Ovarian Cancer, Prostate Cancer
Category(s): Therapeutics, Life Science, Small molecule, Oncology, Diseases